{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:13:35Z","timestamp":1792638815342,"version":"4.5.0"},"reference-count":204,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.canlet.2019.04.033","type":"journal-article","created":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T15:15:58Z","timestamp":1558710958000},"page":"248-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":211,"special_numbering":"C","title":["Shikonin derivatives for cancer prevention and therapy"],"prefix":"10.1016","volume":"459","author":[{"given":"Joelle C.","family":"Boulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Rahama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed-Elamir F.","family":"Hegazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2637-1681","authenticated-orcid":false,"given":"Thomas","family":"Efferth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2019.04.033_bib1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.molmed.2007.07.001","article-title":"From traditional Chinese medicine to rational cancer therapy","volume":"13","author":"Efferth","year":"2007","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.canlet.2019.04.033_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2019.01.009","article-title":"Collateral sensitivity of natural products in drug-resistant cancer cells","author":"Efferth","year":"2019","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.canlet.2019.04.033_bib3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2174\/1389557517666170228114809","article-title":"Advance in anti-tumor mechanisms of shikonin, alkannin and their derivatives","volume":"18","author":"Zhang","year":"2018","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.canlet.2019.04.033_bib4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ptr.1100","article-title":"Cellular pharmacology studies of shikonin derivatives","volume":"16","author":"Chen","year":"2002","journal-title":"Phytother Res."},{"key":"10.1016\/j.canlet.2019.04.033_bib5","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.2174\/09298673113209990008","article-title":"Traditional Chinese medicine remedy to jury: the pharmacological basis for the use of shikonin as an anticancer therapy","volume":"20","author":"Andujar","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.canlet.2019.04.033_bib6","first-page":"2012","article-title":"Shikonin directly targets mitochondria and causes mitochondrial dysfunction in cancer cells","author":"Wiench","year":"2012","journal-title":"Evid. Based Complement Altern. Med."},{"key":"10.1016\/j.canlet.2019.04.033_bib7","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/(SICI)1521-3773(19990201)38:3<270::AID-ANIE270>3.0.CO;2-0","article-title":"The chemistry and biology of alkannin, shikonin, and related naphthazarin natural products","volume":"38","author":"Papageorgiou","year":"1999","journal-title":"Angew. Chem."},{"key":"10.1016\/j.canlet.2019.04.033_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jlac.19365210102","article-title":"Die Konstitution des Alkannins, Shikonins und Alkannans","volume":"521","author":"Brockmann","year":"1936","journal-title":"Justus Liebigs Ann. Chem."},{"key":"10.1016\/j.canlet.2019.04.033_bib9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0031-9422(83)83022-2","article-title":"Formation of stereoisomeric mixtures of naphthoquinone derivatives in Echium lycopsis callus cultures","volume":"22","author":"Fukui","year":"1983","journal-title":"Phytochemistry"},{"key":"10.1016\/j.canlet.2019.04.033_bib10","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0031-9422(00)91425-0","article-title":"Pigment formation in callus cultures of Lithospermum erythrorhizon","volume":"13","author":"Tabata","year":"1974","journal-title":"Phytochemistry"},{"key":"10.1016\/j.canlet.2019.04.033_bib11","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1242\/dev.00647","article-title":"Isolation of pigment cell specific genes in the sea urchin embryo by differential macroarray screening","volume":"130","author":"Calestani","year":"2003","journal-title":"Development"},{"key":"10.1016\/j.canlet.2019.04.033_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.gene.2006.11.005","article-title":"A novel group of type I polyketide synthases (PKS) in animals and the complex phylogenomics of PKSs","volume":"392","author":"Castoe","year":"2007","journal-title":"Gene"},{"key":"10.1016\/j.canlet.2019.04.033_bib13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/157341209787314936","article-title":"Noteworthy secondary metabolites naphthoquinones-their occurrence, pharmacological properties and analysis","volume":"5","author":"Babula","year":"2009","journal-title":"Curr. Pharmaceut. Anal."},{"key":"10.1016\/j.canlet.2019.04.033_bib14","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1039\/C4NP00153B","article-title":"Isolation, biological activity, biosynthesis and synthetic studies towards the rubromycin family of natural products","volume":"32","author":"Atkinson","year":"2015","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.canlet.2019.04.033_bib15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1128\/MR.45.2.316-354.1981","article-title":"Distribution of isoprenoid quinone structural types in bacteria and their taxonomic implication","volume":"45","author":"Collins","year":"1981","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.canlet.2019.04.033_bib16","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2116\/analsci.19.1001","article-title":"Reversed-phase HPLC determination of chlorophyll a' and naphthoquinones in photosystem I of red algae: existence of two menaquinone-4 molecules in photosystem I of Cyanidium caldarium","volume":"19","author":"Yoshida","year":"2003","journal-title":"Anal. Sci. : the international journal of the Japan Society for Analytical Chemistry"},{"key":"10.1016\/j.canlet.2019.04.033_bib17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bbabio.2008.01.011","article-title":"Photosystem I complexes associated with fucoxanthin-chlorophyll-binding proteins from a marine centric diatom, Chaetoceros gracilis","volume":"1777","author":"Ikeda","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2019.04.033_bib18","doi-asserted-by":"crossref","first-page":"16046","DOI":"10.1038\/hortres.2016.46","article-title":"Biosynthesis and molecular actions of specialized 1,4-naphthoquinone natural products produced by horticultural plants","volume":"3","author":"Widhalm","year":"2016","journal-title":"Horticulture research"},{"key":"10.1016\/j.canlet.2019.04.033_bib19","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/0031-9422(79)83012-5","article-title":"Biosynthesis of shikonin in callus cultures of Lithospermum erythrorhizon","volume":"18","author":"Inouye","year":"1979","journal-title":"Phytochemistry"},{"key":"10.1016\/j.canlet.2019.04.033_bib20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.5511\/plantbiotechnology.16.335","article-title":"Shikonin biosynthesis in Lithospermum erythrorhizon. Light-induced negative regulation of secondary metabolism","volume":"16","author":"Yazaki","year":"1999","journal-title":"Plant Biotechnol."},{"key":"10.1016\/j.canlet.2019.04.033_bib21","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.2174\/138527206778742704","article-title":"Recent advances in chemistry, biology and biotechnology of alkannins and shikonins","volume":"10","author":"Papageorgiou","year":"2006","journal-title":"Curr. Org. Chem."},{"key":"10.1016\/j.canlet.2019.04.033_bib22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.molp.2014.12.001","article-title":"A familiar ring to it: biosynthesis of plant benzoic acids","volume":"8","author":"Widhalm","year":"2015","journal-title":"Mol. Plant"},{"key":"10.1016\/j.canlet.2019.04.033_bib23","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1016\/S0040-4039(98)00387-6","article-title":"Shikonin: a geranyl diphosphate-derived plant hemiterpenoid formed via the mevalonate pathway","volume":"39","author":"Li","year":"1998","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.canlet.2019.04.033_bib24","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/S0031-9422(00)82263-3","article-title":"Geranylpyrophosphate, p-hydroxybenzoate geranyltransferase activity in extracts of Lithospermum erythrorhizon cell cultures","volume":"26","author":"Heide","year":"1987","journal-title":"Phytochemistry"},{"key":"10.1016\/j.canlet.2019.04.033_bib25","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0031-9422(95)00633-8","article-title":"Inhibition and regulation of shikonin biosynthesis in suspension cultures of Lithospermum","volume":"41","author":"Gaisser","year":"1996","journal-title":"Phytochemistry"},{"key":"10.1016\/j.canlet.2019.04.033_bib26","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/S0031-9422(00)97877-4","article-title":"Enzymatic regulation of shikonin biosynthesis in Lithospermum erythrorhizon cell cultures","volume":"28","author":"Heide","year":"1989","journal-title":"Phytochemistry"},{"key":"10.1016\/j.canlet.2019.04.033_bib27","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s004250050252","article-title":"Regulatory role of microsomal 3-hydroxy-3-methylglutaryl-coenzyme A reductase for shikonin biosynthesis in Lithospermum erythrorhizon cell suspension cultures","volume":"204","author":"Lange","year":"1998","journal-title":"Planta"},{"key":"10.1016\/j.canlet.2019.04.033_bib28","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1248\/cpb.50.1086","article-title":"Regulation of lithospermic acid B and shikonin production in Lithospermum erythrorhizon cell suspension cultures","volume":"50","author":"Yamamoto","year":"2002","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.canlet.2019.04.033_bib29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1104\/pp.119.2.417","article-title":"Cell-specific production and antimicrobial activity of naphthoquinones in roots of LIthospermum erythrorhizon","volume":"119","author":"Brigham","year":"1999","journal-title":"Plant Physiol."},{"key":"10.1016\/j.canlet.2019.04.033_bib30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1042\/CBI20090459","article-title":"Physico-chemical factors influencing the shikonin derivatives production in cell suspension cultures of Arnebia euchroma (Royle) Johnston, a medicinally important plant species","volume":"35","author":"Malik","year":"2011","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.canlet.2019.04.033_bib31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11240-005-8120-0","article-title":"Effect of light on gene expression and shikonin formation in cultured Onosma paniculatum cells","volume":"84","author":"Liu","year":"2006","journal-title":"Plant cell Tissue Organ Cult."},{"key":"10.1016\/j.canlet.2019.04.033_bib32","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/pcp\/pcn178","article-title":"Nitric oxide regulates shikonin formation in suspension-cultured Onosma paniculatum cells","volume":"50","author":"Wu","year":"2009","journal-title":"Plant Cell Physiol."},{"key":"10.1016\/j.canlet.2019.04.033_bib33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jmgm.2018.04.014","article-title":"Structural dynamics and quantum mechanical aspects of shikonin derivatives as CREBBP bromodomain inhibitors","volume":"83","author":"Mitra","year":"2018","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.canlet.2019.04.033_bib34","doi-asserted-by":"crossref","DOI":"10.1530\/EC-16-0105","article-title":"Anti-tumor effects of shikonin derivatives on human medullary thyroid carcinoma cells","author":"Hasenoehrl","year":"2017","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.canlet.2019.04.033_bib35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejmech.2017.12.019","article-title":"Design and characterization of \u03b1-lipoic acyl shikonin ester twin drugs as tubulin and PDK1 dual inhibitors","volume":"144","author":"Lin","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.canlet.2019.04.033_bib36","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/14756366.2017.1404591","article-title":"Synthesis and antitumor activity of novel 2, 3-didithiocarbamate substituted naphthoquinones as inhibitors of pyruvate kinase M2 isoform","volume":"33","author":"Ning","year":"2018","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.canlet.2019.04.033_bib37","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.biopha.2017.10.159","article-title":"The evaluation of potent antitumor activities of shikonin coumarin-carboxylic acid, PMMB232 through HIF-1\u03b1-mediated apoptosis","volume":"97","author":"Han","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2019.04.033_bib38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bcp.2017.10.009","article-title":"Identification of new shikonin derivatives as STAT3 inhibitors","volume":"146","author":"Qiu","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2019.04.033_bib39","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1038\/s41598-017-02671-7","article-title":"Identification of new shikonin derivatives as antitumor agents targeting STAT3 SH2 domain","volume":"7","author":"Qiu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2019.04.033_bib40","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.3892\/ol.2015.3769","article-title":"\u03b2-hydroxyisovaleryl-shikonin induces human cervical cancer cell apoptosis via PI3K\/AKT\/mTOR signaling","volume":"10","author":"Lu","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2019.04.033_bib41","first-page":"81","article-title":"Pharmacogenomics of a traditional Japanese herbal medicine (Kampo) for cancer therapy","volume":"4","author":"Efferth","year":"2007","journal-title":"Cancer Genom. Proteom."},{"key":"10.1016\/j.canlet.2019.04.033_bib42","doi-asserted-by":"crossref","first-page":"e1600286","DOI":"10.1002\/ardp.201600286","article-title":"Synthesis and evaluation of new naphthalene and naphthoquinone derivatives as anticancer agents","volume":"350","author":"Beretta","year":"2017","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.canlet.2019.04.033_bib43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.archoralbio.2016.06.020","article-title":"Acetylshikonin inhibits growth of oral squamous cell carcinoma by inducing apoptosis","volume":"70","author":"Lee","year":"2016","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.canlet.2019.04.033_bib44","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1016\/j.bmcl.2016.04.006","article-title":"One-pot synthesis of 1, 4-dihydroxy-2-((E)-1-hydroxy-4-phenylbut-3-enyl) anthracene-9, 10-diones as novel shikonin analogs and evaluation of their antiproliferative activities","volume":"26","author":"Zhao","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.canlet.2019.04.033_bib45","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/cbdd.12722","article-title":"Shikonin derivative DMAKO\u201005 inhibits akt signal activation and melanoma proliferation","volume":"87","author":"Yang","year":"2016","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.canlet.2019.04.033_bib46","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1021\/np2006499","article-title":"Naphthoquinones from Onosma paniculata induce cell-cycle arrest and apoptosis in melanoma Cells","volume":"75","author":"Kretschmer","year":"2012","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.canlet.2019.04.033_bib47","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.ejmech.2007.08.009","article-title":"Comparison of the cytotoxic activities of naturally occurring hydroxyanthraquinones and hydroxynaphthoquinones","volume":"43","author":"Cui","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.canlet.2019.04.033_bib48","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.bmcl.2008.12.032","article-title":"Synthesis and biological activity of novel shikonin analogues","volume":"19","author":"Wang","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.canlet.2019.04.033_bib49","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/ijc.21943","article-title":"SH\u20107, a new synthesized shikonin derivative, exerting its potent antitumor activities as a topoisomerase inhibitor","volume":"119","author":"Yang","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2019.04.033_bib50","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.canlet.2008.09.029","article-title":"Naturally-occurring shikonin analogues\u2013a class of necroptotic inducers that circumvent cancer drug resistance","volume":"274","author":"Xuan","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2019.04.033_bib51","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0304-3835(01)00665-6","article-title":"Antitumor activities of a newly synthesized shikonin derivative, 2-hyim-DMNQ-S-33","volume":"172","author":"Kim","year":"2001","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2019.04.033_bib52","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bcp.2015.04.021","article-title":"Synthesis of aryl dihydrothiazol acyl shikonin ester derivatives as anticancer agents through microtubule stabilization","volume":"96","author":"Lin","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2019.04.033_bib53","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/ijc.29483","article-title":"Shikonin and its derivatives inhibit the epidermal growth factor receptor signaling and synergistically kill glioblastoma cells in combination with erlotinib","volume":"137","author":"Zhao","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2019.04.033_bib54","doi-asserted-by":"crossref","first-page":"8871","DOI":"10.1158\/0008-5472.CAN-08-1972","article-title":"Modulation of orphan nuclear receptor Nur77-mediated apoptotic pathway by acetylshikonin and analogues","volume":"68","author":"Liu","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.04.033_bib55","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2014.04.021","article-title":"Acetylshikonin induces apoptosis of hepatitis B virus X protein-expressing human hepatocellular carcinoma cells via endoplasmic reticulum stress","volume":"735","author":"Moon","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.canlet.2019.04.033_bib56","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/cbdd.12077","article-title":"Design, synthesis and biological evaluation of cinnamic acyl shikonin derivatives","volume":"81","author":"Lin","year":"2013","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.canlet.2019.04.033_bib57","first-page":"816","article-title":"Mechanisms of (2-methyl-n-butyl) shikonin induced apoptosis of gastric cancer SGC-7901 cells","volume":"47","author":"Wang","year":"2012","journal-title":"Yao xue xue bao= Acta pharmaceutica Sinica"},{"key":"10.1016\/j.canlet.2019.04.033_bib58","first-page":"2547","article-title":"Inhibition of growth and regulation of IGFs and VEGF in human prostate cancer cell lines by shikonin analogue 93\/637 (SA)","volume":"20","author":"Gaddipati","year":"2000","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2019.04.033_bib59","first-page":"422","article-title":"Detection of the anti-cancer biological effect of naphthoquinone pigment-LIII","volume":"10","author":"Lu","year":"1990","journal-title":"Zhong xi yi jie he za zhi= Chinese journal of modern developments in traditional medicine"},{"key":"10.1016\/j.canlet.2019.04.033_bib60","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1002\/cmdc.201402224","article-title":"Design, synthesis, and biological evaluation of shikonin and alkannin derivatives as potential anticancer agents via a prodrug approach","volume":"9","author":"Wang","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.canlet.2019.04.033_bib61","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/cbdd.12353","article-title":"Novel shikonin derivatives targeting tubulin as anticancer agents","volume":"84","author":"Guo","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.canlet.2019.04.033_bib62","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/cbdd.12247","article-title":"Synthesis and biological evaluation of heterocyclic carboxylic acyl shikonin derivatives","volume":"83","author":"Wang","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.canlet.2019.04.033_bib63","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/chir.22209","article-title":"Design and synthesis of fluoroacylshikonin as an anticancer agent","volume":"25","author":"Kong","year":"2013","journal-title":"Chirality"},{"key":"10.1016\/j.canlet.2019.04.033_bib64","doi-asserted-by":"crossref","first-page":"9184","DOI":"10.3390\/ijms13079184","article-title":"Effect of \u03b2, \u03b2-dimethylacrylshikonin on inhibition of human colorectal cancer cell growth in vitro and in vivo","volume":"13","author":"Fan","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2019.04.033_bib65","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1016\/j.ejmech.2011.05.006","article-title":"Semi-synthesis and antitumor activity of 6-isomers of 5, 8-O-dimethyl acylshikonin derivatives","volume":"46","author":"Zhou","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.canlet.2019.04.033_bib66","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ptr.3503","article-title":"Shikonin derivatives protect immune organs from damage and promote immune responses in vivo in tumour\u2010bearing mice","volume":"26","author":"Long","year":"2012","journal-title":"Phytother Res."},{"key":"10.1016\/j.canlet.2019.04.033_bib67","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejmech.2017.11.031","article-title":"Synthesis and biological evaluation of sulfur-containing shikonin oxime derivatives as potential antineoplastic agents","volume":"143","author":"Huang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.canlet.2019.04.033_bib68","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.2147\/IJN.S132639","article-title":"Successful in vivo hyperthermal therapy toward breast cancer by Chinese medicine shikonin-loaded thermosensitive micelle","volume":"12","author":"Su","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.canlet.2019.04.033_bib69","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/08982104.2014.891233","article-title":"Sterically stabilized liposomes as a potent carrier for shikonin","volume":"24","author":"Kontogiannopoulos","year":"2014","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.canlet.2019.04.033_bib70","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3390\/molecules23020268","article-title":"Anticancer efficacy of targeted shikonin liposomes modified with RGD in breast cancer cells","volume":"23","author":"Wen","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.canlet.2019.04.033_bib71","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.7150\/thno.18299","article-title":"Sarcoma-targeting peptide-decorated polypeptide nanogel intracellularly delivers shikonin for upregulated osteosarcoma necroptosis and diminished pulmonary metastasis","volume":"8","author":"Li","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2019.04.033_bib72","first-page":"1855","article-title":"Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer","volume":"9","author":"Matthaiou","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.canlet.2019.04.033_bib73","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejps.2014.04.009","article-title":"Self-reporter shikonin-Act-loaded solid lipid nanoparticle: formulation, physicochemical characterization and geno\/cytotoxicity evaluation","volume":"59","author":"Eskandani","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.canlet.2019.04.033_bib74","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-3-642-73026-9_11","article-title":"Shikonin: production by plant (Lithospermum erythrorhizon) cell cultures","author":"Fujita","year":"1988","journal-title":"Med. Aromatic Plants I"},{"key":"10.1016\/j.canlet.2019.04.033_bib75","first-page":"4718","article-title":"Hairy root cultures for the production of anti-cancer naphthoquinone compounds","author":"Jeziorek","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.canlet.2019.04.033_bib76","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1074\/jbc.M106387200","article-title":"Geranyl diphosphate: 4-hydroxybenzoate geranyltransferase from Lithospermum erythrorhizon cloning and characterization of a key enzyme in shikonin biosynthesis","volume":"277","author":"Yazaki","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2019.04.033_bib77","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/pcp\/pcd013","article-title":"Genetic engineering on shikonin biosynthesis: expression of the bacterial ubiA gene in Lithospermum erythrorhizon","volume":"41","author":"Boehm","year":"2000","journal-title":"Plant Cell Physiol."},{"key":"10.1016\/j.canlet.2019.04.033_bib78","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1023\/A:1006185806390","article-title":"Genetic engineering of shikonin biosynthesis hairy root cultures of Lithospermum erythrorhizon transformed with the bacterial ubiC gene","volume":"39","author":"Sommer","year":"1999","journal-title":"Plant Mol. Biol."},{"key":"10.1016\/j.canlet.2019.04.033_bib79","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/138945011793591626","article-title":"Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy","volume":"12","author":"Efferth","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.canlet.2019.04.033_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13659-013-0004-0","article-title":"Animal plant warfare and secondary metabolite evolution","volume":"3","author":"W\u00f6ll","year":"2013","journal-title":"Nat. Prod. Bioprospect."},{"key":"10.1016\/j.canlet.2019.04.033_bib81","doi-asserted-by":"crossref","first-page":"e94180","DOI":"10.1371\/journal.pone.0094180","article-title":"An oxidative stress mechanism of shikonin in human glioma cells","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2019.04.033_bib82","first-page":"2016","article-title":"Shikonin attenuates concanavalin A-induced acute liver injury in mice via inhibition of the JNK pathway","author":"Liu","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.canlet.2019.04.033_bib83","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10495-014-0967-2","article-title":"Autophagy and apoptosis: where do they meet?","volume":"19","author":"Mukhopadhyay","year":"2014","journal-title":"Apoptosis"},{"key":"10.1016\/j.canlet.2019.04.033_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2014.12.018","article-title":"Cancer-type-specific crosstalk between autophagy, necroptosis and apoptosis as a pharmacological target","volume":"94","author":"Radogna","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2019.04.033_bib85","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-015-0321-5","article-title":"Apoptosis, autophagy, necroptosis, and cancer metastasis","volume":"14","author":"Su","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2019.04.033_bib86","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejphar.2014.05.034","article-title":"Extracellular signal-regulated kinase, receptor interacting protein, and reactive oxygen species regulate shikonin-induced autophagy in human hepatocellular carcinoma","volume":"738","author":"Gong","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.canlet.2019.04.033_bib87","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3892\/ol.2014.2293","article-title":"Shikonin promotes autophagy in BXPC-3 human pancreatic cancer cells through the PI3K\/Akt signaling pathway","volume":"8","author":"Shi","year":"2014","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2019.04.033_bib88","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1080\/15548627.2017.1386359","article-title":"Necroptosis promotes autophagy-dependent upregulation of DAMP and results in immunosurveillance","volume":"14","author":"Lin","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2019.04.033_bib89","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/cdd.2016.8","article-title":"Cancer therapy in the necroptosis era","volume":"23","author":"Su","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2019.04.033_bib90","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1158\/1535-7163.MCT-06-0511","article-title":"Shikonin circumvents cancer drug resistance by induction of a necroptotic death","volume":"6","author":"Han","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2019.04.033_bib91","series-title":"Materia Medica for Various Cancers","author":"Cho","year":"2011"},{"key":"10.1016\/j.canlet.2019.04.033_bib92","article-title":"Role of NF-\u03baB pathway in shikonin induced apoptosis in oral squamous cell carcinoma Tca-8113 cells","volume":"19","author":"Min","year":"2010","journal-title":"Shanghai J. Stomatol."},{"key":"10.1016\/j.canlet.2019.04.033_bib93","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1601-0825.2010.01758.x","article-title":"Shikonin inhibits tumor invasion via down\u2010regulation of NF\u2010\u03baB\u2010mediated MMP\u20109 expression in human ACC\u2010M cells","volume":"17","author":"Min","year":"2011","journal-title":"Oral Dis."},{"key":"10.1016\/j.canlet.2019.04.033_bib94","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fphar.2011.00049","article-title":"Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review","volume":"2","author":"Porporato","year":"2011","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.canlet.2019.04.033_bib95","first-page":"7423","article-title":"Shikonin, vitamin K3 and vitamin K5 inhibit multiple glycolytic enzymes in MCF-7 cells","volume":"15","author":"Chen","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2019.04.033_bib96","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1517\/13543776.2012.709237","article-title":"Shikonin and its derivatives: a patent review","volume":"22","author":"Wang","year":"2012","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.canlet.2019.04.033_bib97","doi-asserted-by":"crossref","first-page":"45983","DOI":"10.1038\/srep45983","article-title":"Inhibition of pyruvate kinase M2 markedly reduces chemoresistance of advanced bladder cancer to cisplatin","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2019.04.033_bib98","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1055\/a-0599-1145","article-title":"Shikonin prevents early phase inflammation associated with azoxymethane\/dextran sulfate sodium-induced colon cancer and induces apoptosis in human colon cancer cells","volume":"84","author":"And\u00fajar","year":"2018","journal-title":"Planta Med."},{"key":"10.1016\/j.canlet.2019.04.033_bib99","doi-asserted-by":"crossref","first-page":"e0126459","DOI":"10.1371\/journal.pone.0126459","article-title":"Shikonin suppresses skin carcinogenesis via inhibiting cell proliferation","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2019.04.033_bib100","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10549-010-1023-8","article-title":"Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer","volume":"124","author":"Yao","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.canlet.2019.04.033_bib101","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2007.11.007","article-title":"Bypassing cancer drug resistance by activating multiple death pathways\u2013a proposal from the study of circumventing cancer drug resistance by induction of necroptosis","volume":"259","author":"Hu","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2019.04.033_bib102","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.lfs.2018.05.012","article-title":"Shikonin enhances sensitization of gefitinib against wild-type EGFR non-small cell lung cancer via inhibition PKM2\/stat3\/cyclinD1 signal pathway","volume":"204","author":"Tang","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.canlet.2019.04.033_bib103","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/pharmaceutics10030127","article-title":"The effects of synthetically modified natural compounds on ABC transporters","volume":"10","author":"Dantzic","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.canlet.2019.04.033_bib104","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3109\/13880209.2014.952836","article-title":"Effect of shikonin on multidrug resistance in HepG2: the role of SIRT1","volume":"53","author":"Jin","year":"2015","journal-title":"Pharmaceut. Biol."},{"key":"10.1016\/j.canlet.2019.04.033_bib105","doi-asserted-by":"crossref","first-page":"e52706","DOI":"10.1371\/journal.pone.0052706","article-title":"Anticancer agent shikonin is an incompetent inducer of cancer drug resistance","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2019.04.033_bib106","doi-asserted-by":"crossref","first-page":"70504","DOI":"10.18632\/oncotarget.12041","article-title":"Shikonin potentiates the effect of arsenic trioxide against human hepatocellular carcinoma in vitro and in vivo","volume":"7","author":"Song","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2019.04.033_bib107","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1038\/s41598-018-21710-5","article-title":"Broad blocking of MDR efflux pumps by acetylshikonin and acetoxyisovalerylshikonin to generate hypersensitive phenotype of malignant carcinoma cells","volume":"8","author":"Mirzaei","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2019.04.033_bib108","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.3892\/ol.2017.6702","article-title":"Shikonin enhances Adriamycin antitumor effects by inhibiting efflux pumps in A549 cells","volume":"14","author":"Liu","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2019.04.033_bib109","doi-asserted-by":"crossref","first-page":"88658","DOI":"10.18632\/oncotarget.20809","article-title":"Shikonin reduces tamoxifen resistance through long non-coding RNA uc. 57","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2019.04.033_bib110","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3892\/mmr.2017.6729","article-title":"Shikonin promotes adriamycin-induced apoptosis by upregulating caspase-3 and caspase-8 in osteosarcoma","volume":"16","author":"Yang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2019.04.033_bib111","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.bbrc.2015.12.100","article-title":"Enhancement of cisplatin-induced colon cancer cells apoptosis by shikonin, a natural inducer of ROS in vitro and in vivo","volume":"469","author":"He","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2019.04.033_bib112","doi-asserted-by":"crossref","first-page":"38267","DOI":"10.1038\/srep38267","article-title":"Shikonin induces mitochondria-mediated apoptosis and enhances chemotherapeutic sensitivity of gastric cancer through reactive oxygen species","volume":"6","author":"Liang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2019.04.033_bib113","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.phrs.2016.11.011","article-title":"Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway","volume":"115","author":"Li","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.canlet.2019.04.033_bib114","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbrc.2015.10.153","article-title":"MiR-143 enhances the antitumor activity of shikonin by targeting BAG3 expression in human glioblastoma stem cells","volume":"468","author":"Liu","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2019.04.033_bib115","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bcp.2014.01.041","article-title":"Shikonin suppresses tumor growth and synergizes with gemcitabine in a pancreatic cancer xenograft model: involvement of NF-\u03baB signaling pathway","volume":"88","author":"Wang","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2019.04.033_bib116","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s10517-013-2318-7","article-title":"Biopolymeric film containing bioactive naphthoquinone (Shikonin) in combined therapy of Inflammatory destructive lesions in the buccal mucosa","volume":"156","author":"Zagorodnyaya","year":"2013","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.canlet.2019.04.033_bib117","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3389\/fimmu.2015.00663","article-title":"Exploiting the immunogenic potential of cancer cells for improved dendritic cell vaccines","volume":"6","author":"Vandenberk","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2019.04.033_bib118","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3389\/fphar.2017.00386","article-title":"Phytochemicals approach for developing cancer immunotherapeutics","volume":"8","author":"Yin","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.canlet.2019.04.033_bib119","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s00262-012-1258-9","article-title":"Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine","volume":"61","author":"Chen","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.canlet.2019.04.033_bib120","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1423-0127-19-42","article-title":"Shikonin enhances efficacy of a gene-based cancer vaccine via induction of RANTES","volume":"19","author":"Chen","year":"2012","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.canlet.2019.04.033_bib121","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/08923973.2017.1299174","article-title":"Enhancement of NK cells proliferation and function by shikonin","volume":"39","author":"Li","year":"2017","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.canlet.2019.04.033_bib122","doi-asserted-by":"crossref","first-page":"43629","DOI":"10.18632\/oncotarget.9660","article-title":"Immunogenicity of mammary tumor cells can be induced by shikonin via direct binding-interference with hnRNPA1","volume":"7","author":"Yin","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2019.04.033_bib123","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/onc.2009.473","article-title":"B23 acts as a nucleolar stress sensor and promotes cell survival through its dynamic interaction with hnRNPU and hnRNPA1","volume":"29","author":"Yao","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2019.04.033_bib124","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1038\/onc.2013.429","article-title":"microRNA-18a induces apoptosis in colon cancer cells via the autophagolysosomal degradation of oncogenic heterogeneous nuclear ribonucleoprotein A1","volume":"33","author":"Fujiya","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2019.04.033_bib125","doi-asserted-by":"crossref","first-page":"22078","DOI":"10.1074\/jbc.M114.553248","article-title":"Chemical proteomics identifies heterogeneous nuclear ribonucleoprotein (hnRNP) A1 as the molecular target of quercetin in its anti-cancer effects in PC-3 cells","volume":"289","author":"Ko","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2019.04.033_bib126","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1080\/15548627.2017.1386359","article-title":"Necroptosis promotes autophagy-dependent upregulation of DAMP and results in immunosurveillance","volume":"14","author":"Lin","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2019.04.033_bib127","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12943-015-0435-9","article-title":"Shikonin-enhanced cell immunogenicity of tumor vaccine is mediated by the differential effects of DAMP components","volume":"14","author":"Lin","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2019.04.033_bib128","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.biopha.2016.12.023","article-title":"Regulation of miRNAs by herbal medicine: an emerging field in cancer therapies","volume":"86","author":"Mohammadi","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2019.04.033_bib129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2017.12.008","article-title":"Interdependence of GLO I and PKM2 in the Metabolic shift to escape apoptosis in GLO I-dependent cancer cells","volume":"638","author":"Shimada","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.canlet.2019.04.033_bib130","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.3233\/BME-141222","article-title":"A549 cell proliferation inhibited by RNAi mediated silencing of the Nrf2 gene","volume":"24","author":"Zhang","year":"2014","journal-title":"Bio Med. Mater. Eng."},{"key":"10.1016\/j.canlet.2019.04.033_bib131","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.3892\/ol.2014.2018","article-title":"\u03b2, \u03b2-Dimethylacrylshikonin sensitizes human colon cancer cells to ionizing radiation through the upregulation of reactive oxygen species","volume":"7","author":"Kwak","year":"2014","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2019.04.033_bib132","doi-asserted-by":"crossref","first-page":"e0143438","DOI":"10.1371\/journal.pone.0143438","article-title":"The combination of three natural compounds effectively prevented lung carcinogenesis by optimal wound healing","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2019.04.033_bib133","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cbi.2013.06.011","article-title":"The molecular mechanisms and gene expression profiling for shikonin-induced apoptotic and necroptotic cell death in U937 cells","volume":"205","author":"Piao","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.canlet.2019.04.033_bib134","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3892\/ijo.2014.2804","article-title":"Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells","volume":"46","author":"Wada","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2019.04.033_bib135","doi-asserted-by":"crossref","first-page":"38934","DOI":"10.18632\/oncotarget.5380","article-title":"Inhibition of c-MYC with involvement of ERK\/JNK\/MAPK and AKT pathways as a novel mechanism for shikonin and its derivatives in killing leukemia cells","volume":"6","author":"Zhao","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2019.04.033_bib136","first-page":"598","article-title":"[Clinical trial on the effects of shikonin mixture on later stage lung cancer]","volume":"11","author":"Guo","year":"1991","journal-title":"Zhong Xi Yi Jie He Za Zhi"},{"key":"10.1016\/j.canlet.2019.04.033_bib137","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.taap.2016.06.002","article-title":"Modulation of P-glycoprotein activity by novel synthetic curcumin derivatives in sensitive and multidrug-resistant T-cell acute lymphoblastic leukemia cell lines","volume":"305","author":"Ooko","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.canlet.2019.04.033_bib138","first-page":"1","article-title":"Advances in curcumin-loaded nanopreparations: improving bioavailability and overcoming inherent drawbacks","author":"Zhang","year":"2019","journal-title":"J. Drug Target."},{"key":"10.1016\/j.canlet.2019.04.033_bib139","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1080\/10408390802248627","article-title":"Fighting cancer with red wine? Molecular mechanisms of resveratrol","volume":"49","author":"Kraft","year":"2009","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.canlet.2019.04.033_bib140","doi-asserted-by":"crossref","first-page":"152890","DOI":"10.1016\/j.phymed.2019.152890","article-title":"Collateral sensitivity of drug-resistant ABCB5-and mutation-activated EGFR overexpressing cells towards resveratrol due to modulation of SIRT1 expression","author":"Saeed","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.canlet.2019.04.033_bib141","doi-asserted-by":"crossref","first-page":"10210","DOI":"10.1002\/anie.201601967","article-title":"Artemisinin\u2014a gift from traditional Chinese medicine to the world (Nobel lecture)","volume":"55","author":"Tu","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.canlet.2019.04.033_bib142","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2018.05.008","article-title":"Prevention of carcinogenesis and metastasis by artemisinin-type drugs","volume":"429","author":"Abba","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2019.04.033_bib143","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.semcancer.2017.02.009","article-title":"From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy","volume":"46","author":"Efferth","year":"2017","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2019.04.033_bib144","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bcp.2017.03.019","article-title":"Cancer combination therapies with artemisinin-type drugs","volume":"139","author":"Efferth","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2019.04.033_bib145","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.phymed.2018.10.014","article-title":"Effect of Artemisia annua and Artemisia afra tea infusions on schistosomiasis in a large clinical trial","volume":"51","author":"Munyangi","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.canlet.2019.04.033_bib146","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.phymed.2018.06.002","article-title":"The activity of Artemisia spp. and their constituents against trypanosomasis","volume":"47","author":"Na\u00df","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.canlet.2019.04.033_bib147","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.phrs.2016.02.017","article-title":"Antischistosomal activity of artemisinin derivatives in vivo and in patients","volume":"110","author":"Saeed","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.canlet.2019.04.033_bib148","first-page":"4417","article-title":"First study of oral Artenimol-R in advanced cervical cancer: clinical benefit, tolerability and tumor markers","volume":"31","author":"Jansen","year":"2011","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2019.04.033_bib149","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ebiom.2014.11.010","article-title":"A randomised, double blind, placebo-controlled pilot study of oral artesunate therapy for colorectal cancer","volume":"2","author":"Krishna","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.canlet.2019.04.033_bib150","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10549-017-4261-1","article-title":"Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33\/2)","volume":"164","author":"von Hagens","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.canlet.2019.04.033_bib151","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.phymed.2018.09.178","article-title":"Long-term add-on therapy (compassionate use) with oral artesunate in patients with metastatic breast cancer after participating in a phase I study (ARTIC M33\/2)","volume":"54","author":"von Hagens","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.canlet.2019.04.033_bib152","first-page":"1484","article-title":"Shikonin causes apoptosis by disrupting intracellular calcium homeostasis and mitochondrial function in human hepatoma cells","volume":"15","author":"Wang","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.canlet.2019.04.033_bib153","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1038\/s41598-018-21065-x","article-title":"RNA-seq transcriptome analysis of breast cancer cell lines under shikonin treatment","volume":"8","author":"Lin","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2019.04.033_bib154","doi-asserted-by":"crossref","first-page":"32","DOI":"10.7150\/jca.21224","article-title":"Efficacy of shikonin against esophageal cancer cells and its possible mechanisms in vitro and in vivo","volume":"9","author":"Tang","year":"2018","journal-title":"J. Cancer"},{"key":"10.1016\/j.canlet.2019.04.033_bib155","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cbi.2017.06.029","article-title":"Shikonin suppresses proliferation and induces cell cycle arrest through the inhibition of hypoxia-inducible factor-1\u03b1 signaling","volume":"274","author":"Li","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.canlet.2019.04.033_bib156","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s12013-014-0083-5","article-title":"Mechanisms behind the inhibition of lung adenocarcinoma cell by shikonin","volume":"70","author":"Lan","year":"2014","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.canlet.2019.04.033_bib157","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.jep.2013.11.055","article-title":"Shikonin induces cell cycle arrest in human gastric cancer (AGS) by early growth response 1 (Egr1)-mediated p21 gene expression","volume":"151","author":"Kim","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.canlet.2019.04.033_bib158","doi-asserted-by":"crossref","first-page":"E1909","DOI":"10.1210\/jc.2013-2583","article-title":"Shikonin inhibits thyroid cancer cell growth and invasiveness through targeting major signaling pathways","volume":"98","author":"Yang","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.canlet.2019.04.033_bib159","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.canlet.2018.03.046","article-title":"Rip1 and rip3 contribute to shikonin-induced glycolysis suppression in glioma cells via increase of intracellular hydrogen peroxide","volume":"425","author":"Lu","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2019.04.033_bib160","first-page":"5417","article-title":"Shikonin induces mitochondria-mediated apoptosis and attenuates epithelial-mesenchymal transition in cisplatin-resistant human ovarian cancer cells","volume":"15","author":"Shilnikova","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2019.04.033_bib161","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1039\/C6MB00830E","article-title":"Metabolic profiling study of shikonin's cytotoxic activity in the Huh7 human hepatoma cell line","volume":"13","author":"Spyrelli","year":"2017","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.canlet.2019.04.033_bib162","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/mc.21988","article-title":"PKM2 inhibitor shikonin suppresses TPA\u2010induced mitochondrial malfunction and proliferation of skin epidermal JB6 cells","volume":"53","author":"Li","year":"2014","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.canlet.2019.04.033_bib163","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1038\/onc.2011.137","article-title":"Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2","volume":"30","author":"Chen","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2019.04.033_bib164","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1002\/jcb.26128","article-title":"Shikonin inhibited migration and invasion of human lung cancer cells via suppression of c\u2010Met\u2010mediated epithelial\u2010to\u2010mesenchymal transition","volume":"118","author":"Hsieh","year":"2017","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.canlet.2019.04.033_bib165","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1159\/000438596","article-title":"TIPE2 mediates the suppressive effects of shikonin on MMP13 in osteosarcoma cells","volume":"37","author":"Deng","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.canlet.2019.04.033_bib166","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3892\/ol.2014.2771","article-title":"Shikonin induces apoptosis and inhibits migration of ovarian carcinoma cells by inhibiting the phosphorylation of Src and FAK","volume":"9","author":"Hao","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2019.04.033_bib167","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.3892\/or.2014.3159","article-title":"Shikonin blocks migration and invasion of human breast cancer cells through inhibition of matrix metalloproteinase-9 activation","volume":"31","author":"Jang","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2019.04.033_bib168","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.kjms.2011.06.010","article-title":"Glutathione-S-transferase enhances proliferation-migration and protects against shikonin-induced cell death in breast cancer cells","volume":"27","author":"He","year":"2011","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.canlet.2019.04.033_bib169","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.tox.2013.03.015","article-title":"Shikonin attenuates lung cancer cell adhesion to extracellular matrix and metastasis by inhibiting integrin \u03b21 expression and the ERK1\/2 signaling pathway","volume":"308","author":"Wang","year":"2013","journal-title":"Toxicology"},{"key":"10.1016\/j.canlet.2019.04.033_bib170","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1254\/jphs.94.166","article-title":"p53-mediated cell cycle arrest and apoptosis induced by shikonin via a caspase-9-dependent mechanism in human malignant melanoma A375-S2 cells","volume":"94","author":"Wu","year":"2004","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.canlet.2019.04.033_bib171","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/108705710100600206","article-title":"Development and use of a gene promoter-based screen to identify novel inhibitors of cyclooxygenase-2 transcription","volume":"6","author":"Subbaramaiah","year":"2001","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.canlet.2019.04.033_bib172","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1248\/yakushi.128.1681","article-title":"Shikonin, acetylshikonin, and isobutyroylshikonin inhibit VEGF-induced angiogenesis and suppress tumor growth in lewis lung carcinoma-bearing mice","volume":"128","author":"Lee","year":"2008","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.canlet.2019.04.033_bib173","doi-asserted-by":"crossref","first-page":"661","DOI":"10.12659\/MSM.908381","article-title":"Shikonin inhibites migration and invasion of thyroid cancer cells by downregulating DNMT1","volume":"24","author":"Zhang","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.canlet.2019.04.033_bib174","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/1871520617666170919164055","article-title":"Targeting cell necroptosis and apoptosis induced by shikonin via receptor interacting protein kinases in estrogen receptor positive breast cancer cell line, MCF-7","volume":"18","author":"Shahsavari","year":"2018","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"10.1016\/j.canlet.2019.04.033_bib175","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10863-017-9714-z","article-title":"Shikonin induces necroptosis by reactive oxygen species activation in nasopharyngeal carcinoma cell line CNE-2Z","volume":"49","author":"Zhang","year":"2017","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.canlet.2019.04.033_bib176","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/aps.2017.112","article-title":"Shikonin induces glioma cell necroptosis in vitro by ROS overproduction and promoting RIP1\/RIP3 necrosome formation","volume":"38","author":"Bin","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.canlet.2019.04.033_bib177","first-page":"5507","article-title":"Shikonin induces apoptosis and necroptosis in pancreatic cancer via regulating the expression of RIP1\/RIP3 and synergizes the activity of gemcitabine","volume":"9","author":"Chen","year":"2017","journal-title":"Am. J. Tourism Res."},{"key":"10.1016\/j.canlet.2019.04.033_bib178","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12967-017-1223-7","article-title":"Shikonin-induced necroptosis is enhanced by the inhibition of autophagy in non-small cell lung cancer cells","volume":"15","author":"Kim","year":"2017","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.canlet.2019.04.033_bib179","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cbi.2014.01.008","article-title":"Shikonin time-dependently induced necrosis or apoptosis in gastric cancer cells via generation of reactive oxygen species","volume":"211","author":"Lee","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.canlet.2019.04.033_bib180","doi-asserted-by":"crossref","first-page":"e66326","DOI":"10.1371\/journal.pone.0066326","article-title":"Shikonin kills glioma cells through necroptosis mediated by RIP-1","volume":"8","author":"Huang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2019.04.033_bib181","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1186\/1471-2407-13-580","article-title":"The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis","volume":"13","author":"Fu","year":"2013","journal-title":"BMC Canc."},{"key":"10.1016\/j.canlet.2019.04.033_bib182","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s10495-009-0334-x","article-title":"Necrostatin-1 reverts shikonin-induced necroptosis to apoptosis","volume":"14","author":"Han","year":"2009","journal-title":"Apoptosis"},{"key":"10.1016\/j.canlet.2019.04.033_bib183","doi-asserted-by":"crossref","first-page":"12694","DOI":"10.18632\/oncotarget.3031","article-title":"Ferroxitosis: a cell death from modulation of oxidative phosphorylation and PKM2-dependent glycolysis in melanoma","volume":"5","author":"Lakhter","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2019.04.033_bib184","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171546","article-title":"Shikonin suppresses proliferation and induces apoptosis in endometrioid endometrial cancer cells via modulating miR-106b\/PTEN\/AKT\/mTOR signaling pathway","volume":"38","author":"Huang","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.canlet.2019.04.033_bib185","first-page":"3473","article-title":"Shikonin induces apoptosis and G0\/G1 phase arrest of gallbladder cancer cells via the JNK signaling pathway","volume":"38","author":"Zhai","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2019.04.033_bib186","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.phrs.2016.11.011","article-title":"Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway","volume":"115","author":"Li","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.canlet.2019.04.033_bib187","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.3892\/mmr.2017.6965","article-title":"Shikonin suppresses proliferation and induces apoptosis in human leukemia NB4 cells through modulation of MAPKs and c-Myc","volume":"16","author":"Shan","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2019.04.033_bib188","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.biopha.2017.09.023","article-title":"Shikonin suppresses pulmonary fibroblasts proliferation and activation by regulating Akt and p38 MAPK signaling pathways","volume":"95","author":"Nie","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2019.04.033_bib189","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2017.01.008","article-title":"SIRT2 mediated antitumor effects of shikonin on metastatic colorectal cancer","volume":"797","author":"Zhang","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.canlet.2019.04.033_bib190","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3390\/molecules21060777","article-title":"Shikonin inhibits the proliferation of human breast cancer cells by reducing tumor-derived exosomes","volume":"21","author":"Wei","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.canlet.2019.04.033_bib191","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1007\/s13277-015-3157-0","article-title":"Glucose-regulated protein 78 mediates the anticancer efficacy of shikonin in hormone-refractory prostate cancer cells","volume":"36","author":"Kuo","year":"2015","journal-title":"Tumor Biol."},{"key":"10.1016\/j.canlet.2019.04.033_bib192","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3892\/ijo.2014.2306","article-title":"Shikonin inhibits the growth of human prostate cancer cells via modulation of the androgen receptor","volume":"44","author":"Jang","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2019.04.033_bib193","first-page":"2012","article-title":"The critical role of redox homeostasis in shikonin-induced HL-60 cell differentiation via unique modulation of the Nrf2\/ARE pathway","author":"Zhang","year":"2012","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.canlet.2019.04.033_bib194","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10549-010-1023-8","article-title":"Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer","volume":"124","author":"Yao","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.canlet.2019.04.033_bib195","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2009.04.008","article-title":"Shikonin, an ingredient of Lithospermum erythrorhizon, down-regulates the expression of steroid sulfatase genes in breast cancer cells","volume":"284","author":"Zhang","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2019.04.033_bib196","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1002\/ijc.24195","article-title":"Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivo","volume":"124","author":"Yang","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2019.04.033_bib197","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/ptr.2340","article-title":"Growth inhibition and induction of apoptosis in human oral squamous cell carcinoma Tca\u20108113 cell lines by shikonin was partly through the inactivation of NF\u2010\u03baB pathway","volume":"22","author":"Ruan","year":"2008","journal-title":"Phytother. Res."},{"key":"10.1016\/j.canlet.2019.04.033_bib198","first-page":"21","article-title":"The inhibition of N-acetyltransferase activity and gene expression in human bladder cancer cells (T24) by shikonin","volume":"18","author":"Yeh","year":"2004","journal-title":"In Vivo"},{"key":"10.1016\/j.canlet.2019.04.033_bib199","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/j.1349-7006.2002.tb01341.x","article-title":"\u03b2\u2010Hydroxyisovalerylshikonin is a novel and potent inhibitor of protein tyrosine kinases","volume":"93","author":"Hashimoto","year":"2002","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.canlet.2019.04.033_bib200","doi-asserted-by":"crossref","first-page":"109094","DOI":"10.18632\/oncotarget.22618","article-title":"Shikonin induces ROS-based mitochondria-mediated apoptosis in colon cancer","volume":"8","author":"Liang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2019.04.033_bib201","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1349-7006.1992.tb02758.x","article-title":"Modifying effects of fungal and herb metabolites on azoxymethane\u2010induced intestinal carcinogenesis in rats","volume":"83","author":"Yoshimi","year":"1992","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.canlet.2019.04.033_bib202","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.freeradbiomed.2011.09.018","article-title":"Shikonin, a Chinese plant-derived naphthoquinone, induces apoptosis in hepatocellular carcinoma cells through reactive oxygen species: a potential new treatment for hepatocellular carcinoma","volume":"51","author":"Gong","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.canlet.2019.04.033_bib203","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ejphar.2011.02.043","article-title":"Shikonin extracted from medicinal Chinese herbs exerts anti-inflammatory effect via proteasome inhibition","volume":"658","author":"Lu","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.canlet.2019.04.033_bib204","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1349-7006.2008.01049.x","article-title":"Mechanism of inhibition of tumor angiogenesis by \u03b2\u2010hydroxyisovalerylshikonin","volume":"100","author":"Komi","year":"2009","journal-title":"Cancer Sci."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519302708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519302708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T14:05:21Z","timestamp":1608041121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383519302708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":204,"alternative-id":["S0304383519302708"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2019.04.033","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shikonin derivatives for cancer prevention and therapy","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2019.04.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}